Author:
Liu Qingying,Lu Zhongyuan,Ren Huan,Fu Lijun,Wang Yueliang,Bu Huilian,Ma Minyu,Ma Letian,Huang Chen,Wang Jian,Zang Weidong,Cao Jing,Fan Xiaochong
Funder
National Key Research and Development Program of China
International Science and Technology Cooperation Programme
Henan Provincial Science and Technology Research Project
Science and Technology Program of Hunan Province
National Natural Science Foundation of China
Reference64 articles.
1. Cancer to bone: a fatal attraction;Weilbaecher;Nat. Rev. Cancer,2011
2. Pain: Persistent postsurgery and bone cancer-related pain;Feller;J. Int. Med. Res.,2019
3. Pain and nociception: mechanisms of cancer-induced bone pain;Falk;J. Clin. Oncol.,2014
4. Targeting T-type/CaV3.2 channels for chronic pain;Cai;Transl. Res.,2021
5. P.M. Kamau, H. Li, Z. Yao, Y. Han, A. Luo, H. Zhang, C. Boonyarat, C. Yenjai, J. Mwangi, L. Zeng, S. Yang, R. Lai, L. Luo, Potent Ca(V)3.2 channel inhibitors exert analgesic effects in acute and chronic pain models, Biomed Pharmacother 153 (2022) 113310, 10.1016/j.biopha.2022.113310.